Prediction of Significant Hepatic Fibrosis in HCV Carriers With PNALT by SAPI- A Validation Study

NCT00466271 · clinicaltrials.gov ↗
COMPLETED
Status
102
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

National Taiwan University Hospital